Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases
Crossref DOI link: https://doi.org/10.1186/1471-230X-14-184
Published Online: 2014-10-17
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Laass, Martin W
Straub, Simon
Chainey, Suki
Virgin, Garth
Cushway, Timothy
License valid from 2014-10-17
Article History
Received: 30 March 2014
Accepted: 9 October 2014
First Online: 17 October 2014